The invention relates to devices, a systems, and associated methods for use, delivery, and manufacture for changing the blood flow into an aneurysm designed to induce aneurysm thrombosis and/or the exclusion from blood flow and pressure of the aneurysm in order to prevent further growth and eventual rupture.
A brain (cerebral) aneurysm is a protrusion of different shapes from the otherwise smooth cylindrical wall of the vessel, usually caused by a weak area in the vessel wall that gives in under blood pressure. In most cases, a brain aneurysm causes no symptoms and goes unnoticed. In some cases, the brain aneurysm ruptures, causing a hemorrhagic stroke. When a brain aneurysm ruptures in the most common area, the result is a hemorrhage (most commonly subarachnoid). Depending on the severity of the hemorrhage, permanent neurological deficiency or death may result. The most common location for brain aneurysms is in and around the network of blood vessels at the base of the brain called the circle of Willis.
Saccular aneurysm is the most common type of aneurysm. It account for 80% to 90% of all intracranial aneurysms and is the most common cause of non-traumatic subarachnoid hemorrhage (SAH). It is also known as a “berry” aneurysm because of its shape. The berry aneurysm looks like a sac or berry having a neck, or a stem and a sac (body), formed at a bifurcation or on a straight segment of an artery.
Currently, there are three primary treatments for a cerebral aneurysm: (a) craniotomy and surgical clipping, (b) endovascular coiling, and (c) flow diverters. Surgical clipping requires a craniotomy to expose the aneurysm which is then closed by attaching a clip to the neck (base) of the aneurysm, thereby providing a physical barrier to isolate the aneurismal sac. Although effective, this procedure is highly invasive and may require long recovery times. Also, it is available only for aneurisms that are close to the brain surface at an accessible position.
Endovascular coiling is a minimally-invasive procedure in which a pre-shaped coil (typically of shape-memory metal) is released into the aneurismal sac from a catheter. The coil fills the aneurismal sac causing the blood flow within the aneurismal sac to become slow and non-laminar. The blood flow disruption within the aneurismal sac results in the formation of a clot and exclusion of further blood flow into the structure, thereby preventing further expansion of the aneurysm. When successful, the thrombus eventually may be covered by a layer of endothelial cells, reforming the inner vessel wall. However, not all coiling procedures are successful. Coiling may result in aneurysm recanalization in which new routes of blood flow in the aneurism are formed, reapplying blood pressure on the aneurismal wall and further expanding it. Coiling also may require the implantation of additional devices such as stents (in order to retain the coils in the aneurism to prevent their sagging into the parent vessel) and/or the use of multiple coils (released in order to affect clotting in the aneurismal sac). The use of multiple devices increases the procedure time, treatment cost, and probability of an adverse event.
Flow diverters are stent like devices to be deployed in the parent vessel across the neck of the aneurism to alter or restrict blood flow into the aneurysm. The goal of the diverters is to cause thrombosis within the aneurismal sac. Flow diverters have limitations. For example, diverters generally should be used in relatively straight vessels and often do not perform well when the aneurysm is located at or near vessel junctions and bends. Additionally, the gaps between the struts of the diverter in many cases are too large to induce thrombosis in the aneurismal sac or may cause occlusion of the parent vessel due to clotting and/or inflammatory reactions. Finally, the diverter may cause small perforations near the aneurismal neck, causing bleeding, or may occlude nearby small diameter arteries (perforators), each of which may have neurological sequelae.
Accordingly, there is a need for an improved, efficient, and cost effective device and associated methods, for treating cerebral aneurysm, that is independent of the vessel and aneurism anatomy and that will lower the cost and duration of the procedure, as well as reduce the probability of adverse events like perforation, occlusion of nearby perforators and will have higher rate of success in excluding the aneurism.
The present invention relates to clot-forming devices (“CFDs”), systems, and associated methods for use, delivery, and manufacture for changing the blood flow into an aneurysm designed to induce aneurysm thrombosis and/or the exclusion from blood flow and pressure of the aneurysm in order to prevent further growth and eventual rupture.
In one aspect, the invention provides a device having: (a) a central attachment member; (b) a plurality of self-expanding arms attached to the central attachment member and extending radially therefrom and (c) one or more porous panels attached to the arms and extending radially from the central attachment member; wherein the device is configured to adopt a crimped conformation having a first cross-sectional diameter and a deployed conformation having a second cross-sectional diameter that is larger than the first cross-sectional diameter, and a three-dimensional shape that is approximately spherical, semi-spherical, ovoid, or semi-ovoid. Optionally, the device may be used for aneurysm closure according to the methods described herein such that the central attachment member, arms, and mesh panels are sized such that they form a barrier or screen between a vessel and an aneurysm when the device is in the deployed conformation and positioned within the aneurysm.
In some embodiments, the device, including the central attachment member, arms, and mesh panels, are sized to fit within the lumen of a catheter when the device is in the crimped conformation. Optionally, the first cross-sectional diameter fits into a delivery system with a crossing profile less than about 10, 8, or 6 French (i.e., between about 4-10 French, 6-10 French, 4-8 French, or 6-8 French).
In some embodiments, the self-expanding arms comprise a shape memory material that has a memorized shape that defines the three-dimensional shape that is approximately spherical, semi-spherical, ovoid, or semi-ovoid.
In some embodiments, the mesh covering, formed by the one or more mesh panels, extends radially from the central attachment member to a distance of 10% or more of the length of the arms including, for example, at least 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 90% or more of the length of the arms, and including, for example, at least about 10%, 20%, 30%, or 40% and not more than 60%, 70%, 80%, or 90% of the length of the arms. As described herein, the mesh panel(s) may porous and may be formed from a polymer or wire mesh, a perforated polymer membrane, or a mesh of filaments.
In some embodiments, the mesh panels may contain a thrombogenic agent.
In some embodiments, the arms may be substantially linear and may further comprise straight, wavy, or spiral wires. In other embodiments, the arms define a closed shape such as an ellipse, petal shape, or reuleaux triangle. Optionally, the arms are joined by connecting struts that do not contact the attachment member. Optionally, at least one arm also contains a radio-opaque marker at or near a distal end.
In some embodiments, each arm further defines an eyelet at or near a distal end. The eyelets may be integral to the arms or attached to the arms via struts, as described herein.
The attachment member may be annular, toroidal, or any suitable shape in accordance with the principles described herein. Optionally, the attachment member contains one or more holes. Further, the device also main have a thread loop disposed through the one or more holes or eyelets and extending in the proximal direction.
In some embodiments, the device also has a guidewire disposed along a longitudinal axis of the device and through the attachment member annulus or equivalent structure. Optionally, for embodiments in which the arms further defines an eyelet at or near a distal end, the guidewire is further disposed through the eyelets when the device is in the crimped conformation. Such a configuration may be used to maintain the device in the crimped conformation either with or without the use of an external sheath.
In other embodiments, the device also may contain one or more wires attached at a first end and extending into an interior three-dimensional space defined by the arms in the deployed conformation. The wires may be attached at the first end to the attachment member or the arms.
In another aspect, the invention provides methods for closing an aneurysm and/or reducing blood flow through the neck of an aneurysm by deploying within the aneurysm any of the devices described herein. Preferably, the devices are delivered by, and deployed from a catheter.
In one embodiment, the method:
Optionally and as necessary, the method also includes the step of repositioning the device within the aneurysm which is performed after step (d) and repeated as desired. Repositioning may be effected through the use of a device having one or more holes in the central attachment member through which a thread loop is placed to facilitate partial or total device retrieval by the operator, as described in more detail herein.
In some embodiments, the foregoing method causes thrombosis within the aneurysm.
In another aspect, the invention provides systems having a catheter, an aneurysm closure device contained therein in a crimped conformation, and accessory structures to facilitate the delivery, positioning, and retrieval of the device. In one embodiment, the system contains:
“Proximal” is a relative term that refers to the direction or side towards the entry point of the catheter into the vessel. For example, an operator withdrawing a catheter from a patient is translating the catheter in the proximal direction.
“Distal” is a relative term that refers to the direction or side away from the entry point. For example, an operator inserting a catheter into a patient is translating the catheter in a distal direction.
“Top,” when referring to a CFD, is a relative term referring to the portion of the device that is toward the aneurysmal sac or peripheral ends of the device arms.
“Bottom” when referring to a CFD, is a relative term referring to the portion of the device that is toward the aneurysmal neck or the blood vessel.
The present invention provides a self-expanding Clot Forming Device (CFD) designed to be deployed within an aneurysmal sac from a catheter, and its associated delivery devices, methods for use, and methods for manufacture. The CFD may be deployed within an aneurysm located along a substantially straight portion or tortuous portion of a blood vessel wall, or an aneurysm at or near a junction or bifurcation point of a blood vessel(s). Generally, the CFD is formed from a centrally-disposed attachment member (e.g., a ring) having a plurality of arms extending therefrom in a radial pattern. The arms support a mesh covering at least the lower portion of the CFD. The CFD, when deployed, forms a three-dimensional shape that is approximately spherical, semi-spherical, ovoid, or semi-ovoid and is open at the top. The material properties and parameters allow the CFD to self-fit to the aneurismal shape.
Attachment Member
The attachment member is centrally-disposed and configured to provide an attachment point for a plurality of arms. It is sized to fit within the lumen of a catheter or inner member/jacket from which the CFD is to be deployed. There is no limitation on the shape of the attachment member, however, a generally circular shape is preferred such that the shape matches that of the deployment member lumen. In some embodiments, the attachment member is a ring (e.g., a circular ribbon), a toroid, or a disc. (See, for example,
Arms
A plurality of arms (e.g., two, three, four, five, six, seven, eight, or more) are attached to the attachment member on one centrally-disposed end and extend from the attachment member in a radial pattern. The radial pattern may be symmetrical or asymmetrical, but a symmetrical pattern is preferred. The arms may be manufactured as separate elements and subsequently attached to the attachment member, or the arms and attachment member may be manufactured as a single contiguous piece. Optionally, a radio-opaque marker is incorporated or affixed to one or more of the arms. (See, for example,
The arms are constructed to be self-expanding such that the CFD is capable of adopting a crimped conformation and a deployed conformation, the latter being its memorized shape adopted when the CFD is released from the sheath/catheter. In the crimped conformation, the distal ends of the arms are closely disposed to the longitudinal axis of the CFD such that the CFD has a first, smaller diameter adapted to be housed within the catheter or delivery device. When deployed, the arms self-expand to be disposed farther from the longitudinal axis, resulting in the CFD adopting an approximately spherical, semi-spherical, ovoid, or semi-ovoid shape, wherein the CFD has a second, larger diameter defined by the expanded arms. (compare, for example,
The arms, and optionally the attachment member, may be constructed of shape memory materials and using manufacturing methods that are well-known in the art. Specifically, the arms, and optionally the attachment member, may be constructed of known shape memory alloys including, for example, NiTi. These components can be formed by etching or laser cutting a tubing or flat sheet of material into the patterns shown. The components then may be heat treated after formation, as known by those skilled in the art, to take advantage of the shape memory characteristics and/or super elasticity. Metal surfaces may be processed chemically and/or electrochemically in order to achieve the required surface smoothness.
The arms may have any convenient shape suitable for supporting the mesh. For example, arms may be substantially linear elements or may define and enclose a geometric space. In the latter configuration, the geometric space is defined on its perimeter by struts and void in the interior.
Optionally, arms further comprise eyelets at or near the distal end. The eyelets may be integral to the arms or may be attached to the arms by struts. (See, for example,
Optionally, some or all of the arms may be attached on one or both sides to adjacent arms through connectors. Connectors are struts that attach one arm to an adjacent arm but do not attach directly to attachment member. (See, for example,
Mesh Covering
The CFD further comprises a mesh covering supported by the arms. The mesh covering is a porous, semi-porous, or non-porous net made from a mesh of fibers or wires (e.g., metal or thermoplastic polymer such as EPTFE, polyurethane, etc.), or a perforated polymer membrane (e.g., Dacron) having holes. It is configured to limit, change, and/or reduce blood flow into the aneurysmal sac 12 when disposed across the aneurysmal neck 14. The slow and non-linear blood flow occurring through the mesh 130 is intended to cause clotting in the aneurysmal sac 12 such that the clot eventually excludes further blood flow and pressure within the sac 12, thereby preventing expansion and rupture of the aneurysm 10. In some embodiments, the mesh covering is porous to blood cells, platelets, and/or clotting factors.
The mesh is configured to restrict blood flow through the aneurysmal neck 14. Accordingly, the mesh covers at least the bottom 10%, 20%, 30%, 40%, 50%, 75% of the height of the CFD (i.e., the distance H, as illustrated in
The mesh covering may be continuous (i.e., a single piece of mesh to form the covering) or discontinuous (i.e., multiple pieces of mesh that together form the covering). Continuous mesh coverings are illustrated, for example, in
For embodiments in which discontinuous mesh coverings are used, the plurality of mesh panels may be on the same side of the wire frame (i.e., arms and optional connectors) or on opposite sides of the wire frame. For example, all mesh panels may be affixed either to the outer surface or to the inner surface of the arms for support. Alternatively, some mesh panels may be affixed to the outer surface and other mesh panels may be affixed to the inner surface of the arms. In one example, the mesh panels covering or partially covering the voids formed by arms defining a geometric space may be affixed to the inside surface of the arms. Optionally, these mesh panels are creased to fold inward when crimped. And, the mesh panels covering the void space between the arms are affixed to the outside surface of the arms. Optionally, these mesh panels are creased to fold either inward or outward when crimped. In another embodiment in which the CFD is formed from linear arms, the mesh panels covering the void space between the arms may be alternated between the inside and the outside of the wire frame. For example, in a CFD having six arms and therefore defining six separate void spaces between the arms, the first, third, and fifth void space may be covered by mesh panels affixed to the inside of the wire frame, and the second, fourth, and sixth void space may be covered by mesh panels affixed to the outside of the wire frame.
The mesh covering may be configured to limit the outward deflection of the arms in the deployed conformation. For example, the self-expanding arms may be fabricated to have a resting state in which the arms define a CFD structure that is larger than desired for deployment within an aneurysm in order to ensure that the arms have a sufficient opening force to fully deploy the CFD. The circumference/diameter of the deployed conformation may be limited to a size less than the resting state of arms by appropriately limiting the size and shape of the mesh covering. The external or internal surface of CFD (i.e., the arms) may be coated with a polymer mesh by means of, for example, an electrospinning procedure, application of perforated membrane, or metal wire net.
Optionally, one or more of the mesh panels may be coated with a thrombogenic factor. Suitable thrombogenic factors include, for example, Factors VII, VIII, IX, X, XI, and XII. Thrombogenic factors may be encapsulated or incorporated into a polymer coating that is applied to the mesh panels. Alternatively, the thrombogenic factors may be affixed or adhered to the mesh panels (e.g., by dipping and drying).
CFD Construction And Design
The following implementations and embodiments are intended to illustrate additional structural and functional elements of the CFD and the principles of CFD function and design. These embodiments are not intended to be limiting. All components of the delivery catheter shall be fabricated from suitable biocompatible material for interventional invasive use.
In use, CFD 300 may be moved freely along guidewire 350 in its crimped conformation to facilitate accurate positioning of the device in the aneurism. CFD 300 may be ejected from a catheter and yet maintain the crimped conformation by guidewire 350. CFD 300 then may be deployed by withdrawal of guidewire 350 in the proximal direction, freeing eyelets 340, and resulting in expansion of the CFD 300 body under the self-expanding force of arms 320.
Deployment Systems And Methods
The delivery catheter has a pushrod 1194 inserted into the interior lumen 1191 of the outer sheath 1190 and directly abuts the CFD 1100. The pushrod 1194 has an outer diameter glidingly compatible with the inner diameter of the outer sheath 1190. The pushrod 1194 is adapted to move lengthwise inside the interior lumen 1191 of the outer sheath 1190 from the proximal end of the outer sheath 1190 to push and deploy the CFD 1100 in the target implantation site. The pushrod 1194 may be hollow in order to provide passage for an inner lumen, guide wire 1150 and threads 1160 (attached to attachment member 1110) for CFD retraction and repositioning, as described above. The outer sheath 1190 and inner tube 1192 may be equipped with radiopaque markers to be visible in X-Ray and allow a controlled positioning. In this embodiment, the CFD 1100 is held in its crimped conformation by virtue of its placement with the catheter lumen 1191. CFD 1100 deploys immediately upon ejection from the catheter lumen 1191. In one embodiment, distal tip 1196 is attached to the distal end of inner lumen 1192. After CFD 1100 deployment by outer sheath 1190 retraction, distal tip 1196 is withdrawn through the annulus of central attachment member 1110 by withdrawing inner tube 1192. In another embodiment, distal tip 1196 is attached to the distal end of outer sheath 1190 and is sufficiently malleable to allow passage of CFD 1110 through a central annulus upon deployment from outer sheath 1190.
In a related embodiment, the CFD 1300 need not be housed within a catheter or other outer sheath for positioning and deployment because the guidewire 1350 without the outer sheath maintains the CFD 1300 in its crimped conformation, the pushrod 1194 and threads 1160 may be used to translocate the CFD 1300 in both the proximal and distal directions, and the pushrod 1194 may be used to hold the CFD 1300 in place while the guidewire 1350 is withdrawn for deployment. This configuration is less advantageous than catheter delivery because CFD 1300 cannot be easily retracted or partially retracted to facilitate repositioning.
Relatedly, the invention also provides methods for treating and aneurysm and/or implanting a CFD described herein. In one specific embodiment, the method comprises: (i) providing a catheter loaded with a CFD in its crimped conformation, (ii) advancing the catheter of a guidewire to a target aneurysm, (iii) placing the crimped CFD within the aneurysm, optionally based on X-ray image control, (iv) deploying the CFD, optionally based on X-ray image control, (v) repositioning the CFD, if required, and (vi) removing the catheter and the guide wire.
It will be appreciated by persons having ordinary skill in the art that many variations, additions, modifications, and other applications may be made to what has been particularly shown and described herein by way of embodiments, without departing from the spirit or scope of the invention. Therefore it is intended that scope of the invention, as defined by the claims below, includes all foreseeable variations, additions, modifications or applications.
This application claims priority to the United States provisional patent application Ser. No. 62/394,564, filed Sep. 14, 2016. Priority to the provisional patent application is expressly claimed, and the disclosure of the provisional application is hereby incorporated herein by reference in their entireties and for all purposes.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/IB2017/001317 | 9/5/2017 | WO | 00 |
Number | Date | Country | |
---|---|---|---|
62394564 | Sep 2016 | US |